Kymera Therapeutics (KYMR) Other Non-Current Assets (2019 - 2026)
Kymera Therapeutics (KYMR) recorded Other Assets of $13.21 million in Q2 2026, down 19.0% from $16.32 million a year earlier and down 2.2% from the prior quarter.
Powered by 
Analysis
Kymera Therapeutics (KYMR) Other Non-Current Assets (2019 - 2026) Analysis & Trends
At the end of FY2025, Kymera Therapeutics reported Other Assets of $14.91 million, up 92.6% from FY2024.
- Annual Other Assets has a five-year compound annual growth rate of 55.9% (FY2020 to FY2025).
- Across earlier years, Other Assets came in at $7.74 million in FY2024 (-2.3%), $7.93 million in FY2023 (-13.3%), $9.15 million in FY2022 (+12.4%) and $8.14 million in FY2021 (+402.7%).
- The Q2 2026 figure is the lowest quarterly Other Assets since Q1 2025.
- On a year-over-year basis, Other Assets rose in five of the last eight quarters, with growth averaging 62.4%.
- Peak year-over-year performance for Other Assets in the last five years was growth of 402.7% in Q4 2021, against a decline of 32.7% in Q3 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $13.51 million (Q1 2026), $14.91 million (Q4 2025) and $18.4 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 7.70 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 15.10 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 9.42 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 19.90 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 700.00 Mn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 14.60 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 4.90 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 10.02 Bn |
| 10 | Kymera Therapeutics | 11.66 Bn | 8.50 Bn | - | 15.32 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 15.32 Mn |
| Jun 30, 2026 | 13.21 Mn |
| Mar 31, 2026 | 13.51 Mn |
| Dec 31, 2025 | 14.91 Mn |
| Sep 30, 2025 | 18.40 Mn |
| Jun 30, 2025 | 16.32 Mn |
| Mar 31, 2025 | 9.12 Mn |
| Dec 31, 2024 | 7.74 Mn |
| Sep 30, 2024 | 5.78 Mn |
| Jun 30, 2024 | 5.84 Mn |
| Mar 31, 2024 | 7.94 Mn |
| Dec 31, 2023 | 7.93 Mn |
| Sep 30, 2023 | 8.60 Mn |
| Jun 30, 2023 | 8.60 Mn |
| Mar 31, 2023 | 9.30 Mn |
| Dec 31, 2022 | 9.15 Mn |
| Sep 30, 2022 | 9.13 Mn |
| Jun 30, 2022 | 8.54 Mn |
| Mar 31, 2022 | 8.13 Mn |
| Dec 31, 2021 | 8.14 Mn |
API Access
Kymera Therapeutics Other Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=KYMR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-assets", "ticker": "KYMR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=KYMR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();